With a host of projects on our plate, there are few that require a public focus.
BioExec Institute 2008
The BioExec Institute 2008 is an internationally renowned executive program delivered by leaders in the industry to director- and vp-level managers who are searching for the keys to managing business trade-offs within a highly regulated and competitive industry.
Module A – Creating Value | October 8-9 2008
Module B – Managing Value | November 3-4, 2008
Module C – Growing Value | December 8-9, 2008
Alongside BioExec Institute 2008 faculty and alumni, attendees will participate in a six-day (3 modules of 2 days each) interactive program, including three evening networking receptions. Participants will have unique opportunities to discuss and debate the strategies and tactics of business leadership within BioPharma and will complete the program with invaluable insight and powerful networks to deliver bottom-line value in this growing industry.
Listen to a sneak preview of what to expect at this year's Institute, as well as background about the value it provides to both its attendees and faculty:
To use our embedded media player, please install the latest version of Adobe Flash Player.
Partial list of confirmed and invited faculty:
- Martin Babler, President and CEO, Talima Therapeutics Inc.
- R.T. (Terry) Hisey, Vice Chairman and U.S. Life Sciences Leader, Deloitte & Touche USA LLP
- Barbara Ryan, Chief Analyst, Deutsche Bank
- Mervyn Turner, Ph.D. Senior Vice President, Worldwide Licensing and External Research
- David A. Kessler, M.D., Dean & Vice Chancellor for Medical Affairs, UCSF School of Medicine, and former Commissioner of the FDA
- Gareth Morgan, Executive Director, Central Clinical Operations, Bristol-Myers Squibb
- Eric J. Patzer, Ph.D., President and CEO, Aridis Pharmaceuticals, LLC
- Steve Buckanavage, Vice President, Global Marketing, Oncology & Infection Therapy Area, AstraZeneca Pharmaceuticals
- Chris Horan, Vice President, Planning, Distribution and Logistics, Genentech, Inc.
- Lucy Rose, Managing Director Life Sciences Regulatory & Capital Markets Consulting Deloitte & Touche LLP
The California Center for Healthcare and Biomedical Technology Hospital
The CCHBT Hospital, a 200,000 sq ft Private-Physician Hospital, will join the San Jose BioCenter in the burgeoning Edenvale Research Park mid-2009. The CCHBT Hospital will focus heavily on patients with musculoskeletal, cardiovascular, and oncology-related disorders, and provide specialization in other areas such as urology, gynecology, general surgery, podiatry, and gastroenterology. Dedicated to medical innovation, the hospital will have access to state-of-the-art surgical and imaging equipment, as well as medical procedures. “It's going to be a facility unlike any other facility. This project will redefine the delivery of healthcare and innovative medicine while closing the gap between technology and clinical practice" says Dr. James Lilja, Board Member of the CCHBT Research Foundation. » read more
BioCenter Expansion: Reserve Your Lab Now!
The BioCenter recently kicked off the expansion to 80,000sf with second stage lab spaces of 5,000 – 10,000 sf. Applications to reserve lab spaces are now available. If you’d like to be considered as a BioCenter company, please click and fill in the application form. The BioCenter does not take any IP or equity stakes. Our goal is to level the playing field for small companies by providing the same type of infrastructure that project teams in large companies have access to. For more information, please contact Gayle Fagan at gayle@sjbiocenter.com or 408.960.3805. » read more
Canada’s Top 10 Life Science Companies Competition
First held in 1999, Canada’s Top 10 Competition was designed to promote the 10 most promising life science companies from across Canada (5 Early stage and 5 Emerging/Late stage) to Canadian and international investors and partners. Winners are chosen by an independent expert panel of Canadian and US venture capitalists. The Consulate General of Canada in San Francisco and Presience Internatioanl hosts a series of meetings and receptions for Canada's leading life science CEOs, including Canada’s Top 10 Life Science Companies. » read more